These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 798148)

  • 1. Effect of trimethylcolchicinic acid methyl ether d-tartrate (TMCA) on Hodgkin's and non-Hodgkin's lymphoma.
    Stolinsky DC; Jacobs EM; Irwin LE; Pajak TF; Bateman JR
    Oncology; 1976; 33(4):151-3. PubMed ID: 798148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma.
    Stolinsky DC; Solomon J; Weiner JM; Bateman JR
    Oncology; 1976; 33(5-6):271-3. PubMed ID: 800240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Hodgkin's disease and other malignant lymphomas.
    Aungst CW
    J Surg Oncol; 1973 Jun; 5(6):575-9. PubMed ID: 4589653
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas.
    Host H; Abrahamsen AF
    Scand J Haematol; 1973; 10(3):170-6. PubMed ID: 4588616
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTIC (NSC-45388) studies in the southwest oncology group.
    Costanzi JJ
    Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies.
    Hu E; Ko R; Koda R; Rosen P; Jeffers S; Scholtz M; Muggia F
    Cancer Chemother Pharmacol; 1990; 26(5):359-64. PubMed ID: 2208579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary observations on the results of treating malignant lymphoma with Lycurim].
    Polubiec A; Kolakowska-Polubiec K; Mariańska B; Perzanowska I
    Acta Haematol Pol; 1977; 8(3):213-9. PubMed ID: 200051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion.
    Jackson DV; Paschold EH; Spurr CL; Muss HB; Richards F; Cooper MR; White DR; Stuart JJ; Hopkins JO; Rich R
    Cancer; 1984 Jun; 53(12):2601-6. PubMed ID: 6722721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of vinblastine for maintenance therapy in malignant lymphomas.
    Klener P; Donner L; Ort J
    Neoplasma; 1974; 21(3):323-9. PubMed ID: 4608740
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Sacks P; Jacobs P; Gale D; Lynch SR; Bothwell TH; Stevens K
    S Afr Med J; 1973 Jun; 47(21):903-7. PubMed ID: 4351107
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 17. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
    Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.